Are you Dr. Cho-Phan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 67 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
875 Blake Wilbur Dr
# Stanford
Stanford, CA 94304Phone+1 650-498-6000
Summary
- Dr. Cheryl Cho-Phan, MD is an oncologist in Stanford, California. She is currently licensed to practice medicine in California and Oregon. She is affiliated with Stanford Health Care and is a Clinical Assistant Professor at Stanford University Medical Center.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1999 - 2002
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1996 - 1999
- Georgetown University School of MedicineClass of 1996
Certifications & Licensure
- OR State Medical License 1997 - Present
- CA State Medical License 1999 - 2025
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies Start of enrollment: 2010 Sep 01
- Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- 7 citationsCopy Number as a Quantitative Biomarker for Real-World Outcomes to Anti-Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal Adenocarcinoma.Liangliang Zhang, Omar Hamdani, Ole Gjoerup, Cheryl Cho-Phan, Jeremy Snider
JCO Precision Oncology. 2022-01-01 - 36 citationsLimitations of body surface area-based activity calculation for radioembolization of hepatic metastases in colorectal cancer.Marnix G.E.H. Lam, John D. Louie, M. Abdelmaksoud, George A. Fisher, Cheryl D. Cho-Phan
Journal of Vascular and Interventional Radiology. 2014-07-01 - 5 citationsRAS Amplification as a Negative Predictor of Benefit from Anti-EGFR–Containing Therapy Regimens in Metastatic Colorectal CancerAlexa B. Schrock, J. Lee, Jaideep Sandhu, Russell Madison, Cheryl D. Cho-Phan
The Oncologist. 2021-06-01